Castle Biosciences Correlations
CSTL Stock | USD 30.28 0.16 0.53% |
The current 90-days correlation between Castle Biosciences and Caredx Inc is 0.32 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Castle Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Castle Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Castle Biosciences Correlation With Market
Modest diversification
The correlation between Castle Biosciences and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Castle Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Castle |
Moving together with Castle Stock
0.64 | GANX | Gain Therapeutics | PairCorr |
0.64 | CMND | Clearmind Medicine Common | PairCorr |
0.66 | CPRX | Catalyst Pharmaceuticals | PairCorr |
Moving against Castle Stock
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Castle Stock performing well and Castle Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Castle Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CDNA | 2.55 | (0.38) | 0.00 | (0.26) | 0.00 | 4.19 | 24.22 | |||
TWST | 3.12 | (0.09) | 0.03 | 0.09 | 3.73 | 8.94 | 17.59 | |||
BDSX | 2.61 | (0.28) | 0.00 | 4.87 | 0.00 | 5.95 | 29.48 | |||
NTRA | 2.28 | 0.44 | 0.17 | 0.57 | 2.15 | 4.30 | 25.26 | |||
GTH | 1.87 | 0.00 | (0.03) | 0.13 | 2.49 | 3.45 | 14.43 | |||
OLK | 0.63 | 0.19 | 0.05 | (0.80) | 0.48 | 1.58 | 4.37 | |||
FONR | 1.50 | (0.15) | 0.00 | (0.09) | 0.00 | 2.15 | 10.84 | |||
XGN | 3.75 | 0.47 | 0.13 | 0.60 | 3.40 | 9.62 | 25.65 | |||
PSNL | 4.38 | (0.50) | 0.00 | (0.26) | 0.00 | 8.46 | 35.38 | |||
GH | 2.88 | 0.29 | 0.14 | 0.29 | 2.55 | 8.24 | 17.48 |
Castle Biosciences Corporate Management
Camilla Zuckero | Exec Communications | Profile | |
John Abbott | VP Controller | Profile | |
RN RN | Chief Officer | Profile | |
Kristen RN | Chief Officer | Profile | |
Tobin Juvenal | Chief Officer | Profile |